ClinicalTrials.Veeva

Menu

Impact of Transcranial Direct Current Stimulation of the Motor Cortex on Language Functions in Residual Aphasia (StimRAph)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Unknown

Conditions

Residual Aphasia

Treatments

Device: atDCS
Device: sham tDCS

Study type

Interventional

Funder types

Other

Identifiers

NCT01845129
RAPH_01EO0801

Details and patient eligibility

About

The present study assesses whether language functions in patients with residual post-stroke aphasia can be improved by transcranial direct current stimulation administered to the primary motor cortex in the language dominant (left) hemisphere.

Full description

Patients will participate in two tDCS sessions (atDCS; sham) in a cross-over within subjects design. tDCS or placebo will be administered during simulatneous fMRI to assess neural signatures of the stimulation. Order of stimulation will be counterbalanced between subjects

Enrollment

16 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • right handedness
  • German native speaker
  • cerebrovascular stroke in left hemisphere (>6 months)
  • mild aphasia (according to Aachen Aphasia Test Battery Classification, Huber et al., 1983)
  • residual anomia in naming test (>75 correct responses)

Exclusion criteria

  • other current or previous neurological or psychiatric diseases
  • alcohol or drug abuse
  • MRI contraindication (e.g. magnetic metal, pacemaker, claustrophobia)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

16 participants in 2 patient groups

anodal tDCS
Experimental group
Description:
atDCS will be administered for 20 minutes with 1 milliampere (1 mA) to the left primary hand motor cortex
Treatment:
Device: sham tDCS
Device: atDCS
sham tDCS
Sham Comparator group
Description:
sham tDCS will be administered to the left primary hand motor cortex
Treatment:
Device: sham tDCS
Device: atDCS

Trial contacts and locations

1

Loading...

Central trial contact

Robert Darkow, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems